ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CGEM Cullinan Oncology Inc

18.06
0.18 (1.01%)
Apr 18 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 702,321
Bid Price 18.10
Ask Price 18.50
News -
Day High 19.19

Low
7.64

52 Week Range

High
20.0639

Day Low 17.95
Company Name Stock Ticker Symbol Market Type
Cullinan Oncology Inc CGEM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.18 1.01% 18.06 18:15:13
Open Price Low Price High Price Close Price Prev Close
18.00 17.95 19.19 18.06 17.88
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,663 702,321 $ 18.46 $ 12,968,326 - 7.64 - 20.0639
Last Trade Time Type Quantity Stock Price Currency
19:23:04 1 $ 18.48 USD

Cullinan Oncology (CGEM) Options Flow Summary

Overall Flow

Bullish

Net Premium

27k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Cullinan Oncology Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
777.77M 43.07M - 0 -153.16M -3.56 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cullinan Oncology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CGEM Message Board. Create One! See More Posts on CGEM Message Board See More Message Board Posts

Historical CGEM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week17.4620.063916.3217.41955,7110.603.44%
1 Month15.6820.063915.6817.19481,1362.3815.18%
3 Months12.6820.063912.4617.15498,5105.3842.43%
6 Months8.9820.06397.6414.64343,9619.08101.11%
1 Year10.7120.06397.6413.08292,9227.3568.63%
3 Years35.0337.607.3014.97269,208-16.97-48.44%
5 Years42.0059.857.3017.38273,890-23.94-57.00%

Cullinan Oncology Description

Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Your Recent History

Delayed Upgrade Clock